These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 21371482)

  • 1. Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders.
    Vaccarino FM; Stevens HE; Kocabas A; Palejev D; Szekely A; Grigorenko EL; Weissman S
    Neuropharmacology; 2011 Jun; 60(7-8):1355-63. PubMed ID: 21371482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual Research Review: The promise of stem cell research for neuropsychiatric disorders.
    Vaccarino FM; Urban AE; Stevens HE; Szekely A; Abyzov A; Grigorenko EL; Gerstein M; Weissman S
    J Child Psychol Psychiatry; 2011 Apr; 52(4):504-16. PubMed ID: 21204834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling neurological disorders by human induced pluripotent stem cells.
    Kunkanjanawan T; Noisa P; Parnpai R
    J Biomed Biotechnol; 2011; 2011():350131. PubMed ID: 22162635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons.
    Tamburini C; Li M
    Brain Pathol; 2017 Jul; 27(4):508-517. PubMed ID: 28585386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.
    Moad M; Pal D; Hepburn AC; Williamson SC; Wilson L; Lako M; Armstrong L; Hayward SW; Franco OE; Cates JM; Fordham SE; Przyborski S; Carr-Wilkinson J; Robson CN; Heer R
    Eur Urol; 2013 Nov; 64(5):753-61. PubMed ID: 23582880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating human neurons in vitro and using them to understand neuropsychiatric disease.
    Paşca SP; Panagiotakos G; Dolmetsch RE
    Annu Rev Neurosci; 2014; 37():479-501. PubMed ID: 25002278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments.
    Zhang X; Li Z; Liu Y; Gai Z
    Int J Med Sci; 2021; 18(2):459-473. PubMed ID: 33390815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling neurodevelopmental disorders using human neurons.
    Chailangkarn T; Acab A; Muotri AR
    Curr Opin Neurobiol; 2012 Oct; 22(5):785-90. PubMed ID: 22717528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
    Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
    Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons.
    Shum C; Macedo SC; Warre-Cornish K; Cocks G; Price J; Srivastava DP
    Horm Behav; 2015 Aug; 74():228-42. PubMed ID: 26143621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
    van Hugte E; Nadif Kasri N
    Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of psychiatric disorders using induced pluripotent stem cell-related technologies.
    Nakazawa T; Hashimoto R; Takuma K; Hashimoto H
    J Pharmacol Sci; 2019 Aug; 140(4):321-324. PubMed ID: 31257060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Human Induced Pluripotent Stem Cells into Cortical Neurons to Advance Precision Medicine.
    Silva MC; Nandi G; Haggarty SJ
    Methods Mol Biol; 2022; 2429():143-174. PubMed ID: 35507160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome comparison of human neurons generated using induced pluripotent stem cells derived from dental pulp and skin fibroblasts.
    Chen J; Lin M; Foxe JJ; Pedrosa E; Hrabovsky A; Carroll R; Zheng D; Lachman HM
    PLoS One; 2013; 8(10):e75682. PubMed ID: 24098394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells and hepatic differentiation.
    Chiang CH; Huo TI; Sun CC; Hsieh JH; Chien Y; Lu KH; Lee SD
    J Chin Med Assoc; 2013 Nov; 76(11):599-605. PubMed ID: 23933345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.
    Cerneckis J; Cai H; Shi Y
    Signal Transduct Target Ther; 2024 Apr; 9(1):112. PubMed ID: 38670977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.